Literature DB >> 16286361

Effect of medium type, age and aeration on the MICs of tigecycline and classical tetracyclines.

R Hope1, M Warner, S Mushtaq, M E Ward, T Parsons, D M Livermore.   

Abstract

BACKGROUND: Tigecycline is a minocycline derivative, belonging to a chemical class prone to oxidation and to medium-related effects on susceptibility. We therefore studied the effect of medium type and age on the tigecycline MICs found in broth and on agar by the Clinical Laboratory Standards Institute and British Society for Applied Chemotherapy methods.
METHODS: MICs of tigecycline, minocycline and tetracycline were determined for 96 non-fastidious bacteria and 20 streptococci using Mueller-Hinton broth (MHB), Mueller-Hinton agar (MHA), Iso-Sensitest broth (ISB) and Iso-Sensitest agar (ISA) as: (i) freshly-prepared media; (ii) fresh media but with the antibiotic added 1 day before inoculation and (iii) media stored for 7 days before antibiotic addition and use.
RESULTS: MICs of tigecycline in fresh MHB were up to two doubling dilutions higher than on or in MHA, ISA or ISB. Media with tigecycline or classical tetracyclines added a day before use gave raised MICs, though rarely by more than one dilution. MICs of tigecycline (less so classical tetracyclines) were increased in 7-day-old MHB or ISB, even though the antibiotic was freshly added. This latter effect was greatest for the most susceptible strains and was absent or much reduced for organisms with MICs > or = 8 mg/L; it did not occur in the corresponding agar dilution tests. Addition of blood to MHB largely abrogated the effect, as did steaming the broth before adding the antibiotic.
CONCLUSIONS: The raised MICs of tigecycline in aged broth probably reflect inactivation by dissolved oxygen. This accords with the lack of any MIC increase in newly-steamed (i.e. degassed) MHB or on aged agar (which is melted at 100 degrees C before use). Blood, which also abrogated the effect, may increase reducing capacity, protecting the tigecycline. At a practical level, broth MIC determinations for tigecycline should always employ fresh media.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286361     DOI: 10.1093/jac/dki386

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  15 in total

1.  Synergistic interactions of Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro wound model.

Authors:  Stephanie DeLeon; Allie Clinton; Haley Fowler; Jake Everett; Alexander R Horswill; Kendra P Rumbaugh
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

2.  Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Rat Pneumonia Model.

Authors:  Ziad Tarazi; Mojgan Sabet; Michael N Dudley; David C Griffith
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010.

Authors:  Jien-Wei Liu; Wen-Chien Ko; Cheng-Hua Huang; Chun-Hsing Liao; Chin-Te Lu; Yin-Ching Chuang; Shih-Ming Tsao; Yao-Shen Chen; Yung-Ching Liu; Wei-Yu Chen; Tsrang-Neng Jang; Hsiu-Chen Lin; Chih-Ming Chen; Zhi-Yuan Shi; Sung-Ching Pan; Jia-Ling Yang; Hsiang-Chi Kung; Chun-Eng Liu; Yu-Jen Cheng; Yen-Hsu Chen; Po-Liang Lu; Wu Sun; Lih-Shinn Wang; Kwok-Woon Yu; Ping-Cherng Chiang; Ming-Hsun Lee; Chun-Ming Lee; Gwo-Jong Hsu; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 4.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

5.  Activity of Tigecycline or Colistin in Combination with Zidovudine against Escherichia coli Harboring tet(X) and mcr-1.

Authors:  Yu-Feng Zhou; Ping Liu; Shu-He Dai; Jian Sun; Ya-Hong Liu; Xiao-Ping Liao
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  Comparison of tigecycline and vancomycin for treatment of experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus.

Authors:  Pierre Vaudaux; Bénédicte Fleury; Asllan Gjinovci; Elzbieta Huggler; Manuela Tangomo-Bento; Daniel P Lew
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

7.  Tigecycline Efflux as a Mechanism for Nonsusceptibility in Acinetobacter baumannii.

Authors:  Anton Y Peleg; Jennifer Adams; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2007-04-09       Impact factor: 5.191

8.  Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.

Authors:  Yu-Chung Chuang; Chien-Yu Cheng; Wang-Huei Sheng; Hsin-Yun Sun; Jann-Tay Wang; Yee-Chun Chen; Shan-Chwen Chang
Journal:  BMC Infect Dis       Date:  2014-02-24       Impact factor: 3.090

9.  The Integrity of Heme Is Essential for Reproducible Detection of Metronidazole-Resistant Clostridioides difficile by Agar Dilution Susceptibility Tests.

Authors:  Xiaoqian Wu; Wan-Jou Shen; Aditi Deshpande; Abiola O Olaitan; Kelli L Palmer; Kevin W Garey; Julian G Hurdle
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

10.  Effect of different Mueller-Hinton agars on tigecycline disc diffusion susceptibility for Acinetobacter spp.

Authors:  Visanu Thamlikitkul; Surapee Tiengrim
Journal:  J Antimicrob Chemother       Date:  2008-06-21       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.